CBIZ Inc
Professional Services
CBIZ Inc (CBZ) Stock News
The latest CBZ headlines and market coverage — 2 recent stories, updated throughout the day.
- Zacks Investment Research·
3 Reasons Why Growth Investors Shouldn't Overlook CBIZ (CBZ)
CBIZ (CBZ) is highlighted as an attractive growth stock with a Zacks Rank #2 (Buy) and Growth Score of B. The company demonstrates strong fundamentals including 15.4% projected EPS growth (above 11.6% industry average), exceptional 80.5% year-over-year cash flow growth (versus 6.1% industry average), and positive earnings estimate revisions. These factors position CBIZ as a potential outperformer for growth investors.
- GlobeNewswire Inc.·
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.